When Perrigo Co. announced that it was purchasing Elan Corp. plc. for $8.6 billion last month, Perrigo's relocation to Ireland to take advantage of the country's 12.5 percent corporate tax rate was cited as one of the driving forces for the transaction. (See BioWorld Today, July 30, 2013.) Read More
For research purposes, the molecule JQ1 is being given away literally for the asking by its makers. But that doesn't mean it's a free-for-all as far as the medical potential of its molecular cousins is concerned. Read More
FinancingsAcceleron Pharma Inc. has filed for an initial public offering (IPO) that aims to raise about $74.7 million.Apexigen Inc. raised $20 million in a Series A1 financing to advance its cancer therapy, APX005.Engene Inc. completed an initial closing of a $13.25 million financing led by Lumira Capital.Intrexon Corp. priced its IPO of about 10 million shares at $16 apiece. Read More
